Over the last decades, CD95L and other death-inducing ligands of the TNF super-family, such as TNF and TNF related apoptosis inducing ligand (TRAIL), have garnered significant attention due to their potential to trigger the programmed cell death of apoptosis [3] and their further application in cancer therapy [4]. This evidence concerns the gene TNFSF10 and cancer.